Skip to content
10-Q

Quarterly Report

CORE LABORATORIES INC. CLB

0000950170-25-058900

← back to feed
Filed
Apr 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 18, 2025 46.88M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $124.37M
Long Term Debt Q1 2025 · Dec 31, 2024 $126.11M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $22.11M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $19.16M
Stockholders Equity Q1 2025 · Mar 31, 2025 $253.39M
Stockholders Equity Q1 2025 · Dec 31, 2024 $251.99M
Current Liabilities Q1 2025 · Mar 31, 2025 $103.73M
Current Liabilities Q1 2025 · Dec 31, 2024 $97.59M
Current Assets Q1 2025 · Mar 31, 2025 $228.77M
Current Assets Q1 2025 · Dec 31, 2024 $226.61M
Total Assets Q1 2025 · Dec 31, 2024 $590.41M
Total Assets Q1 2025 · Mar 31, 2024 $587.95M
Shares Diluted Q1 2025 · Mar 31, 2024 47.7M sh
Stock Repurchased Q1 2025 · Mar 31, 2024 $44K
Dividends Paid Q1 2025 · Mar 31, 2024 $468K
Capex Q1 2025 · Mar 31, 2024 $3.05M
Operating Cash Flow Q1 2025 · Mar 31, 2024 $5.53M
Eps Diluted Q1 2025 · Mar 31, 2024 $0.07
Eps Basic Q1 2025 · Mar 31, 2024 $0.07
Sga Expense Q1 2025 · Mar 31, 2024 $11.79M
Net Income Q1 2025 · Mar 31, 2024 $3.22M
Operating Income Q1 2025 · Mar 31, 2024 $8.57M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $104.59M
Revenue Q1 2025 · Mar 31, 2024 $129.64M